QR Code

B Cell Activating Factor Induces Drug Resistance in Hairy Cell Leukemia Variant

<b>Background:</b> Chemoresistance is an existing challenge faced in the treatment of the hairy cell leukemia variant (HCL-v). Classical hairy cell leukemia (HCL-c) is very sensitive to the standard of care with purine nucleoside analogs (PNAs) cladribine (cDa) and pentostatin. However, almost half...

Description complète

Enregistré dans:
Auteurs principaux: Claire Fritz, Daniel Feinberg, Akshaya Radhakrishnan, Kayla Klatt, E. Ricky Chan, Philip Rock, Richard Burack, Reshmi Parameswaran
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2025-04-01
Collection:Biomedicines
Sujets:
hairy cell leukemia
chemoresistance
BAFF
HCL
Leukemia
chemo-protection
Accès en ligne:https://www.mdpi.com/2227-9059/13/4/890
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires